Symbiosis Pharmaceutical

Activities: Manufacturing

Trending Articles

  1. Navigating AI Integration in medical device manufacturing: risks, requirements and best practices This article explores the regulatory, technical and strategic considerations associated with integrating AI into medical devices, highlighting SaMD classification, compliance...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...
  4. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding...
  5. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets

Symbiosis appoints Joanne Anderson as chief commercial officer

Strategic return strengthens commercial leadership as sterile fill-finish CDMO expands global footprint
Finance

Symbiosis begins commercial manufacturing at new FDA-inspected facility

Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill-finish contract manufacturing organisation (CMO), has manufactured its first 10,000-vial batch at the company’s new facility in Stirling, UK
Manufacturing

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
Manufacturing

Symbiosis reaches major milestone with 1,000th batch of injectable drug product

Symbiosis Pharmaceutical Services, a global contract manufacturing organisation (CMO), today announced the successful completion of its 1,000th sterile drug product batch, marking a significant milestone in its mission to accelerate access to life-changing medicines worldwide
Manufacturing

Symbiosis appoints Angelika Rublack as Senior Business Development Manager

Symbiosis expands global reach with key appointment of Angelika Rublack as Senior Business Development Manager

Symbiosis honoured with prestigious King’s Award for Enterprise for International Trade

Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill finish of injectable drug products has been awarded a 2025 King’s Award for Enterprise in the International Trade category, the UK’s highest official accolade for British businesses
Subscribe now